Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study-Reference-Cited by-同舟云学术

Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study

Published:2022-07 Issue: Volume:Volume 15 Page:3957-3974
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Wang Li,Zhang Yu-Ling,Jiang Chang,Duan Fang-Fang^ORCID,Yuan Zhong-Yu,Huang Jia-Jia,Bi Xi-Wen

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Cancer Statistics, 2021

2. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

3. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines

4. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

5. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of lymphocyte-C-reactive protein ratio in the prognosis of gastrointestinal cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-08-29

2. Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis;Frontiers in Oncology;2023-10-02

3. Prognostic value of lymphocyte-to-C-reactive-protein ratio in cancers;2023-05-18